This month, the Sabin Vaccine Institute will begin a Phase-1 clinical trial in Washington, DC to further investigate the Na-GST-1 human hookworm vaccine candidate.

Dengue outbreaks occur in countries throughout the world on an all too frequent basis. One of the latest countries to experience an outbreak of the disease is the Philippines.

For the past week, the Sabin Vaccine Institute and the Global Network for Neglected Tropical Diseases have been working with a group of organizations to raise awareness of specific issues - such a

Each year since 1994 the Sabin Vaccine Institute has  recognized distinguished members of the scientific community  with its highest honor, the Albert B. Sabin Gold Medal Award.  Gold Medal Award winners have made significant contributions  to vaccinology or a complementary field.

Pages